Journal Club: All Recent News

Sandoz receives positive CHMP opinion for proposed biosimilar infliximab

(Mar 23 2018)

Amgen And Allergan Receive Positive CHMP Opinion For ABP 980 (Biosimilar Herceptin) For The Treatment Of Three Types Of Cancer

(Mar 23 2018)

Nippon Kayaku Receives Manufacture and Marketing Approval in Japan for Biosimilar of Trastuzumab Monoclonal Antibody

(Mar 23 2018)

Trump Policy Change Is a Win for Drugmakers

(Mar 22 2018)

Britain's use of copycat biotech drugs takes off while US lags

(Mar 21 2018)

Mundipharma expands biosimilar portfolio with exclusive partnership deal across seven European countries for trastuzumab biosimilar, Herzuma

(Mar 20 2018)

Biocon Sees Approvals Unlocking $1 Billion Biosimilar Business

(Mar 20 2018)

Wyoming Governor Mead Signs Bill Facilitating Patient Access to Interchangeable Biologic Medicines

(Mar 18 2018)

Allergan CEO: We Are Looking at All Options to Create Shareholder Value

(Mar 15 2018)

Roche CEO says new drugs will offset biosimilar incursions

(Mar 13 2018)

ViewPoints: Coherus steps back into the race for Neulasta biosimilar

(Mar 12 2018)

The First Biosimilar Monoclonal Antibody In Oncology, Redditux (Rituximab Biosimilar) Ready For Launch In Turkey

(Mar 9 2018)

Charles River Laboratories Makes Expansions to Global Biologics Infrastructure

(Mar 8 2018)

GC Pharma gets Korean approval for Lantus biosimilar

(Mar 8 2018)

CEO Albrecht to modernize STADA – Biosimilars to focus on oncology, CNS, diabetes and ophthalmology

(Mar 8 2018)

Launch of first breast cancer biosimilar in the UK

(Mar 8 2018)

Celltrion reshuffles top executives for overseas push

(Mar 7 2018)

Capturing the Benefits of Competition for Patients

(Mar 7 2018)

Cancer Chemotherapy and Pharmacology has published comparative data of rituximab biosimilar RTXM83R in lymphoma patients

(Mar 6 2018)

ViewPoints: European payers gear up for 2018's biosimilar windfall

(Mar 6 2018)

Pages